Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,974 | -78,823 | -33,940 | 7,998 | -41,936 |
| Depreciation Amortization | -3,570 | -2,869 | -1,681 | -7,175 | -5,660 |
| Accounts receivable | -28,382 | -14,375 | -1,128 | -8,175 | -773 |
| Other Working Capital | -12,541 | -11,471 | -10,419 | -1,809 | 8,869 |
| Other Operating Activity | 47,086 | 27,204 | 6,426 | 22,709 | 11,044 |
| Operating Cash Flow | $-127,381 | $-80,334 | $-40,742 | $13,548 | $-28,456 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 38,853 | 77,777 | 29,155 | -98,038 | -1,580 |
| PPE Investments | -339 | -142 | -91 | -563 | -261 |
| Purchase Sale Intangibles | -5,860 | N/A | N/A | -7,500 | -2,500 |
| Other Investing Activity | -5,860 | 0 | 0 | -7,500 | -2,500 |
| Investing Cash Flow | $32,654 | $77,635 | $29,064 | $-106,101 | $-4,341 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 100,327 | N/A | N/A | 69,383 | N/A |
| Common Stock Issued | 3,901 | 3,422 | 725 | 3,016 | 1,483 |
| Other Financing Activity | -761 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $103,467 | $3,422 | $725 | $72,399 | $1,483 |
| Beginning Cash Position | 50,817 | 50,817 | 50,817 | 70,971 | 70,971 |
| End Cash Position | 59,557 | 51,540 | 39,864 | 50,817 | 39,657 |
| Net Cash Flow | $8,740 | $723 | $-10,953 | $-20,154 | $-31,314 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,381 | -80,334 | -40,742 | 13,548 | -28,456 |
| Capital Expenditure | -339 | -142 | -91 | -563 | -261 |
| Free Cash Flow | -127,720 | -80,476 | -40,833 | 12,985 | -28,717 |